Low molecular weight heparin for intravenous drug users with deep vein thrombosis

Emergency Medicine Journal

Volumn 21, Issue 6, 2004, Pages 711-

  Russell, Michael ^a   Dawson, Deborah ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; COUMARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULATION; BLOOD ANALYSIS; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HUMAN; INFORMATION PROCESSING; INTRAVENOUS DRUG ABUSE; METHODOLOGY; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; SHORT SURVEY; ADULT; REVIEW; SUBSTANCE ABUSE; VEIN THROMBOSIS;

ADULT; ANTICOAGULANTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; SUBSTANCE ABUSE, INTRAVENOUS; VENOUS THROMBOSIS; WARFARIN;

EID: 16644396142     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2004.019653     Document Type: Short Survey

References (3)

1. Mackenzie AR, Laing RB, Douglas JG, et al. High prevalence of iliofemoral venous thrombosis with severe groin infection among injecting drug users in north east Scotland: successful use of low molecular weight heparin with antibiotics. Postgrad Med J 2000; 76:561-5.
2. Lawson WL, Robertson LT, Tait RC. Management of intravenous drug users with venous thromboembolism. Br J Haematol 2003;121(suppl 1):19.
3. Lane B, Harrison M. Low molecular weight heparin or unfractionated heparin in the treatment of patients with uncomplicated deep vein thrombosis. J Accid Emerg Med 2000;17:402-3.